Clinical boundary Schedule I in the U.S. Serious cardiac risk Not FDA-approved No dosing or referrals Schedule I · cardiac risk Not FDA-approved · no referrals

Search IbogaBase

Search the full catalog of studies, trials, laws, policy records, media, cultural sources, and reference pages. Every result links to its original source. This is an educational finding aid — no dosing, no referrals, no medical advice.

Try QT prolongation · Texas SB 2308 · Noribogaine FDA · Bwiti stewardship